The increased fluorescence intensity of Ang1 suggests that aCD19 Ab treatment exerts a protective and pro-angiogenic effect on damaged neural and vascular structures following stroke (Figure 4a, Supplementary Figure S3a). The gene discussed is ANGPT1; the disease is Stroke.